Eeva Piitulainen

Malmoe, M 20502, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 37 publications

From Birth to Midlife-Liver Function, Fibrosis and Mortality in Individuals with Severe Alpha-1-Antitrypsin Deficiency Identified by Neonatal Screening.

From Birth to Midlife-Liver Function, Fibrosis and Mortality in Individuals with Severe Alpha-1-Antitrypsin Deficiency Identified by Neonatal Screening.

Journal: Journal of clinical medicine

Published: February 17, 2026

COVID-19 outcomes in individuals with severe alpha-1 antitrypsin deficiency in Sweden.

COVID-19 outcomes in individuals with severe alpha-1 antitrypsin deficiency in Sweden.

Journal: Scientific reports

Published: September 24, 2025

Signs of Hyperinflation and Ventilation Heterogeneity in Individuals With Severe Alpha-1-Antitrypsin Deficiency at the Age of 42.

Signs of Hyperinflation and Ventilation Heterogeneity in Individuals With Severe Alpha-1-Antitrypsin Deficiency at the Age of 42.

Journal: International journal of chronic obstructive pulmonary disease

Published: August 02, 2024

COVID-19 in Individuals with Severe Alpha 1-Antitrypsin Deficiency.

COVID-19 in Individuals with Severe Alpha 1-Antitrypsin Deficiency.

Journal: International journal of chronic obstructive pulmonary disease

Published: July 29, 2024

Severe α1-Antitrypsin Deficiency and Increased Risk of Gastrointestinal Diseases.

Severe α1-Antitrypsin Deficiency and Increased Risk of Gastrointestinal Diseases.

Journal: Mayo Clinic proceedings

Published: March 15, 2024

Cancer risk in severe alpha-1 antitrypsin deficiency: the importance of early identification.

Cancer risk in severe alpha-1 antitrypsin deficiency: the importance of early identification.

Journal: The European respiratory journal

Published: April 22, 2022

Cancer risk in severe alpha-1-antitrypsin deficiency.

Cancer risk in severe alpha-1-antitrypsin deficiency.

Journal: The European respiratory journal

Published: December 19, 2021

The Clinical Course of Severe Alpha-1-Antitrypsin Deficiency in Patients Identified by Screening.

The Clinical Course of Severe Alpha-1-Antitrypsin Deficiency in Patients Identified by Screening.

Journal: International journal of chronic obstructive pulmonary disease

Published: September 20, 2021

Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42.

Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42.

Journal: International journal of chronic obstructive pulmonary disease

Published: September 04, 2021

Severe alpha-1-antitrypsin deficiency increases the risk of venous thromboembolism.

Severe alpha-1-antitrypsin deficiency increases the risk of venous thromboembolism.

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 15, 2020

Cardiac troponins - biomarkers for cardiovascular disease in chronic obstructive pulmonary disease

Cardiac troponins - biomarkers for cardiovascular disease in chronic obstructive pulmonary disease

Journal: Lakartidningen

Published: February 26, 2020

Decreased Risk of Ischemic Heart Disease in Individuals with Severe Alpha 1-Antitrypsin Deficiency (PiZZ) in Comparison with the General Population.

Decreased Risk of Ischemic Heart Disease in Individuals with Severe Alpha 1-Antitrypsin Deficiency (PiZZ) in Comparison with the General Population.

Journal: International journal of chronic obstructive pulmonary disease

Published: January 27, 2020

Showing 1-12 of 37

Last Updated: 09/26/2026